Skip to main content

McKesson to Offer Proventys' Personalized Medicine Service

This article has been updated to include comments from a McKesson official.
 
NEW YORK (GenomeWeb News) – McKesson today announced that it would offer a personalized medicine knowledge service developed by privately held Proventys.
 
Durham, NC-based Proventys translates predictive data from traditional and emerging diagnostic tests — including genomics, proteomics, and metabolomics — into clinical decision support products.  
 
The firms will develop decision-support solutions that will work with McKesson's clinical applications that incorporate clinical, environmental, and genomic information to help providers determine the best course of treatment for an individual patient, Andrew Mellin, vice president of advanced clinical technology, McKesson Provider Technologies, told GenomeWeb Daily News via e-mail.
"We see Proventys’ solutions as having applicability to a broad spectrum of users in healthcare," said Mellin. "Certainly, physicians will benefit from having this type of information to provide more informed, individualized decisions. We also see these tools being helpful for payors and other constituents in healthcare." 

Proventys’ knowledge base will be added to McKesson’s Horizon Knowledge Center clinical content offering, the Atlanta-based firm said in a statement. Mellin added that Proventys' risk-prediction capabilities may eventually be incorporated into a broader  suite of healthcare solutions from McKesson.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.